Consultant Clinical Oncologist
0161 446 3337
MB ChB, MRCP (UK), FRCR
Started at The Christie (Year)
- Executive Medical Director
- Consultant Clinical Oncologist with an interest in lung cancer
Dr Bayman joined The Christie in 2009 as a consultant clinical oncologist with an interest in lung cancer. He has extensive system leadership experience and was the inaugural Greater Manchester Cancer Alliance Clinical Director for Lung Cancer from January 2014 to June 2017. In this role he was responsible for delivering transformation of lung cancer pathways and multidisciplinary working, improving access and reducing waiting times for patients across the region.
During his career, Dr Bayman has led practice changing research in lung cancer and mesothelioma, and has held a number of national positions including Specialist Advisor for Oncology for the Care Quality Commission, membership of NHS England’s Chemotherapy Clinical Reference Group and Lung Cancer Clinical Expert Group, and membership of the Royal College of Radiologists’ Clinical Oncology Faculty Board and Professional Support and Standards Board.
Dr Bayman was appointed as Executive Medical Director from November 2021, having been interim Medical Director since April 2021, and the Trust’s Associate Medical Director (Quality) since June 2017. He holds strategic positions both regionally and nationally and has a proven track record on influencing cancer policy. He has significant expertise in fostering clinical engagement, delivering transformation and safeguarding quality and patient safety through robust clinical governance.
His qualifications include Fellowship of the Royal College of Radiologists (FRCR), Membership of the Royal College of Physicians (MCRP) and Bachelor of Medicine, Bachelor of Surgery (MBCHB).